Induction of Anti-Tumor Immunity with Epidermal Cells Pulsed with Tumor-Derived RNA or Intradermal Administration of RNA

This publication has 14 references indexed in Scilit:

• Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
  Nature Biotechnology, 1998
• Bone Marrow–generated Dendritic Cells Pulsed with Tumor Extracts or Tumor RNA Induce Antitumor Immunity against Central Nervous System Tumors
  The Journal of Experimental Medicine, 1997
• Regulation of tumor antigen presentation by urocanic acid.
  The Journal of Immunology, 1997
• Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo.
  The Journal of Experimental Medicine, 1996
• Dermal Dendritic Cells are Important Members of the Skin Immune System
  Published by Springer Nature ,1995
• Interleukin 1α but Not Transforming Growth Factor β Inhibits Tumor Antigen Presentation by Epidermal Antigen-Presenting Cells
  Journal of Investigative Dermatology, 1994
• Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.
  The Journal of Experimental Medicine, 1989
• Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells.
  The Journal of Experimental Medicine, 1987
• Immunologic properties of purified epidermal Langerhans cells. Distinct requirements for stimulation of unprimed and sensitized T lymphocytes.
  The Journal of Experimental Medicine, 1986
• Immunosuppressor T Cells in Tumor Bearing Hosts
  Immunological Communications, 1975